Dabigatran Etexilate - Latest Advances

Effect of Direct Oral Anticoagulants Versus Traditional Anticoagulation in Budd-Chiari Syndrome.

Journal: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis

Published: September 30, 2025

Cost Differences Between Oral Anticoagulation Therapies in Patients with Atrial Fibrillation in Finland.

Journal: Drugs - real world outcomes

Published: September 22, 2025

Intracranial Hemorrhage With Direct Oral Anticoagulants vs Low-Molecular-Weight Heparin in Brain Tumors: A Review and Meta-Analysis.

Journal: Neurology

Published: September 15, 2025

Persistent Challenges in Direct Oral Anticoagulant Prescriptions: Time to Optimize Medication Safety in Hospital and Community Settings.

Journal: The Israel Medical Association journal : IMAJ

Published: September 11, 2025

Intraoperative antithrombotic drug removal during heart transplantation: A case series from the International Safe and Timely Antithrombotic Removal (STAR) registry.

Journal: JHLT open

Published: September 11, 2025

A real-world safety evaluation of new oral anticoagulants in elderly patients: evidence from the Adverse Drug Reaction Monitoring Center of Henan Province.

Journal: Journal of pharmaceutical policy and practice

Published: September 05, 2025

Efficacy and Safety of Direct Oral Anticoagulants in Budd-Chiari Syndrome After Percutaneous Recanalization.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: August 12, 2025

Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients With Mechanical Heart Valves: A Systematic Review.

Journal: Cureus

Published: August 09, 2025

Hemorrhage Risk Associated with Anticoagulant and Antiplatelet Drug Combinations: Insights from the USFDA Adverse Event Reporting System.

Journal: Journal of clinical medicine

Published: August 08, 2025

Evaluation of the treatment patterns among commercially insured patients with nonvalvular atrial fibrillation prescribed an oral anticoagulant by race/ethnicity.

Journal: Journal of comparative effectiveness research

Published: August 05, 2025

Tenecteplase-What Have We Learned till Now? A Narrative Review.

Journal: Life (Basel, Switzerland)

Published: August 05, 2025

Comparative analysis of all-cause health care resource utilization and costs among patients with non-valvular atrial fibrillation and high risk of gastrointestinal bleeding in France: a nationwide cohort analysis.

Journal: Journal of medical economics

Published: August 05, 2025

Filters

Effect of Direct Oral Anticoagulants Versus Traditional Anticoagulation in Budd-Chiari Syndrome.

Effect of Direct Oral Anticoagulants Versus Traditional Anticoagulation in Budd-Chiari Syndrome.

Cost Differences Between Oral Anticoagulation Therapies in Patients with Atrial Fibrillation in Finland.

Cost Differences Between Oral Anticoagulation Therapies in Patients with Atrial Fibrillation in Finland.

Intracranial Hemorrhage With Direct Oral Anticoagulants vs Low-Molecular-Weight Heparin in Brain Tumors: A Review and Meta-Analysis.

Intracranial Hemorrhage With Direct Oral Anticoagulants vs Low-Molecular-Weight Heparin in Brain Tumors: A Review and Meta-Analysis.

Persistent Challenges in Direct Oral Anticoagulant Prescriptions: Time to Optimize Medication Safety in Hospital and Community Settings.

Persistent Challenges in Direct Oral Anticoagulant Prescriptions: Time to Optimize Medication Safety in Hospital and Community Settings.

Intraoperative antithrombotic drug removal during heart transplantation: A case series from the International Safe and Timely Antithrombotic Removal (STAR) registry.

Intraoperative antithrombotic drug removal during heart transplantation: A case series from the International Safe and Timely Antithrombotic Removal (STAR) registry.

A real-world safety evaluation of new oral anticoagulants in elderly patients: evidence from the Adverse Drug Reaction Monitoring Center of Henan Province.

A real-world safety evaluation of new oral anticoagulants in elderly patients: evidence from the Adverse Drug Reaction Monitoring Center of Henan Province.

Efficacy and Safety of Direct Oral Anticoagulants in Budd-Chiari Syndrome After Percutaneous Recanalization.

Efficacy and Safety of Direct Oral Anticoagulants in Budd-Chiari Syndrome After Percutaneous Recanalization.

Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients With Mechanical Heart Valves: A Systematic Review.

Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients With Mechanical Heart Valves: A Systematic Review.

Hemorrhage Risk Associated with Anticoagulant and Antiplatelet Drug Combinations: Insights from the USFDA Adverse Event Reporting System.

Hemorrhage Risk Associated with Anticoagulant and Antiplatelet Drug Combinations: Insights from the USFDA Adverse Event Reporting System.

Evaluation of the treatment patterns among commercially insured patients with nonvalvular atrial fibrillation prescribed an oral anticoagulant by race/ethnicity.

Evaluation of the treatment patterns among commercially insured patients with nonvalvular atrial fibrillation prescribed an oral anticoagulant by race/ethnicity.

Tenecteplase-What Have We Learned till Now? A Narrative Review.

Tenecteplase-What Have We Learned till Now? A Narrative Review.

Comparative analysis of all-cause health care resource utilization and costs among patients with non-valvular atrial fibrillation and high risk of gastrointestinal bleeding in France: a nationwide cohort analysis.

Comparative analysis of all-cause health care resource utilization and costs among patients with non-valvular atrial fibrillation and high risk of gastrointestinal bleeding in France: a nationwide cohort analysis.